LAMATTINA JOHN L (CIK 1216074) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Sell LGND (232 shares), Sell LGND (697 shares), Sell LGND (3,405 shares), Sell LGND (257 shares), Buy LGND (836 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 232 | $57,562 |
| 2026-06-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 697 | $173,922 |
| 2026-06-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 3,405 | $856,766 |
| 2026-06-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 257 | $63,536 |
| 2026-06-09 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 836 | $0 |
| 2026-03-31 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 2,161 | $246,678 |
| 2026-03-31 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 2,161 | $433,842 |
| 2025-11-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 2,034 | $417,885 |
| 2025-11-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 2,145 | $141,849 |
| 2025-11-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Sell | 2,145 | $440,690 |
| 2025-11-12 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 2,034 | $141,383 |
| 2025-06-10 | LIGAND PHARMACEUTICALS INC (LGND) | Director | Buy | 1,209 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-12